It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Diabetic retinopathy is a common complication of long-term diabetes and that could lead to vision loss. Unfortunately, early diabetic retinopathy remains poorly understood. There is no effective way to prevent or treat early diabetic retinopathy until patients develop later stages of diabetic retinopathy. Elevated acellular capillary density is considered a reliable quantitative trait present in the early development of retinopathy. Hence, in this study, we interrogated whole retinal vascular transcriptomic changes via a Nile rat model to better understand the early pathogenesis of diabetic retinopathy. We uncovered the complexity of associations between acellular capillary density and the joint factors of blood glucose, diet, and sex, which was modeled through a Bayesian network. Using segmented regressions, we have identified different gene expression patterns and enriched Gene Ontology (GO) terms associated with acellular capillary density increasing. We developed a random forest regression model based on expression patterns of 14 genes to predict the acellular capillary density. Since acellular capillary density is a reliable quantitative trait in early diabetic retinopathy, and thus our model can be used as a transcriptomic clock to measure the severity of the progression of early retinopathy. We also identified NVP-TAE684, geldanamycin, and NVP-AUY922 as the top three potential drugs which can potentially attenuate the early DR. Although we need more in vivo studies in the future to support our re-purposed drugs, we have provided a data-driven approach to drug discovery.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of California Santa Barbara, Neuroscience Research Institute, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676)
2 University of California Santa Barbara, Neuroscience Research Institute, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676); University of California Santa Barbara, Department of Molecular, Cellular and Developmental Biology, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676)
3 Cleveland State University, Department of Biological, Geological and Environmental Sciences, Cleveland, USA (GRID:grid.254298.0) (ISNI:0000 0001 2173 4730); Cleveland State University, Center for Gene Regulation in Health and Disease, Cleveland, USA (GRID:grid.254298.0) (ISNI:0000 0001 2173 4730)
4 Morgridge Institute For Research, Madison, USA (GRID:grid.509573.d) (ISNI:0000 0004 0405 0937)
5 University of California Santa Barbara, Neuroscience Research Institute, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676); University of California Santa Barbara, Department of Molecular, Cellular and Developmental Biology, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676); Morgridge Institute For Research, Madison, USA (GRID:grid.509573.d) (ISNI:0000 0004 0405 0937)
6 Cleveland State University, Department of Biological, Geological and Environmental Sciences, Cleveland, USA (GRID:grid.254298.0) (ISNI:0000 0001 2173 4730); Cleveland State University, Center for Gene Regulation in Health and Disease, Cleveland, USA (GRID:grid.254298.0) (ISNI:0000 0001 2173 4730); Case Western Reserve University, Center for RNA Science and Therapeutics, School of Medicine, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)